Showing 5831-5840 of 6035 results for "".
- Alcon to Showcase Latest Innovations at American Academy of Ophthalmology 2018 Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-at-american-academy-of-ophthalmology-2018-annual-meeting/2479748/Alcon will showcase several advancements in ophthalmology through a robust booth presence, a series of live demonstrations, and interactive symposia during the American Academy of Ophthalmology (AAO) 2018 annual meeting, taking place October 27-30 in Chicago, IL. “We are very excited to e
- FDA Warns Against Using Raindrop Near Vision Inlayhttps://modernod.com/news/fda-warns-against-using-raindrop-near-vision-inlay/2479749/The FDA today issued an alert about an increased risk for corneal haze in patients with the Raindrop Near Vision Inlay (Optics Medical). The FDA issued the alert after 75% of patients in a postapproval study of the device developed corneal haze, according to a
- Bausch + Lomb to Launch First-in-Class Surgical Support Applications for Stellaris Elite on IBM Cloudhttps://modernod.com/news/bausch-lomb-to-launch-first-in-class-surgical-support-applications-for-stellaris-elite-on-ibm-cloud/2479752/Bausch + Lomb and IBM announced the launch of the new eyeTELLIGENCE applications which will run on the IBM Cloud to help eye surgeons and surgical facilities work more efficiently using Stellaris Elite vision enhancement systems. The companies built the eyeTELLIGENCE applications to deliver surge
- New CorneaGen Interactive Education Program To Offer Free Online Training for Surgeonshttps://modernod.com/news/new-corneagen-interactive-education-program-to-offer-free-online-training-for-all-surgeons/2479755/CorneaGen is adding interactive, online courses to its free education program for surgeons around the world. Utilizing an online platform designed for universities, CorneaGen will offer instruction in cutting-edge procedures such as Nano-Thin DSEK and best practices for using transplant devices.
- Cell Care Therapeutics Raises $4.3 Million in Seed Fundinghttps://modernod.com/news/cell-care-therapeutics-raises-4-3-million-in-seed-funding/2479765/Cell Care Therapeutics announced the closing of a $4.3 million seed round investment from a syndicate of individual investors. This round of funding will be used to develop Cell Care’s manufacturing platform and to ad
- IDx and Topcon Sign Exclusive AI Platform Agreement For the U.S. Markethttps://modernod.com/news/idx-and-topcon-sign-exclusive-ai-platform-agreement-for-the-u-s-market/2479766/AI diagnostics company IDx and Topcon have signed an exclusivity agreement that will allow the companies to scale delivery of AI-based diagnostic solutions in the United States. Terms of the deal were not disclosed. The agreement grants exclusive rights to IDx in the US as the only
- OWL to Host Signature Event and Awards Ceremony at AAO 2018https://modernod.com/news/owl-to-host-signature-event-and-awards-ceremony-at-aao-2018/2479767/OWL: Advancing Diversity in Leadership (OWL) announced that it will host its annual OWL Signature Event and Awards Ceremony at the American Academy of Ophthalmology (AAO). OWL’s largest event of the year will take place on Sunday, October 28, 2018 from 5:30-7:00 p.m., at Revel Motor Row in Chicag
- Orasis Announces the Appointment of Jeffry Weinhuff as Chairman of the Board of Directorshttps://modernod.com/news/orasis-announces-the-appointment-of-jeffry-weinhuff-as-chairman-of-the-board-of-directors/2479771/Orasis Pharmaceuticals announced the appointment of Jeffry Weinhuff as chairman of the board of directors. As a managing partner of Visionary Ventures, Mr. Weinhuff joins the Orasis board of directors in conjunction with the recent Series B financing led by Visionary Ventures, a venture capital f
- Takeda Gets Japanese Approval for $62 Billion Shire Purchasehttps://modernod.com/news/takeda-gets-japanese-approval-for-62-billion-shire-purchase/2479773/Takeda Pharmaceutical reported that Japan’s Fair Trade Commission had approved its $62 billion acquisition of Shire, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker, according to
- I-MED Pharma Partners With Quidel to Introduce I-Lid ’N Lash, I-Relief, and SMTube to the US Markethttps://modernod.com/news/i-med-pharma-partners-with-quidel-to-introduce-i-lid-n-lash-i-relief-and-smtube-to-the-us-market/2479777/I-MED Pharma, a company specializing in dry eye diagnosis and management, announced the signing of an exclusive distribution agreement with Quidel Corporation, a leading provider of rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, for I-MED Pha